Sun Pharma Advanced Research Company Limited (SPARC.NS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap63.70B
EV63.70B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Revenue
20.2
18.8
19.5
21.9
9.5
22.1
9.3
30.6
16.6
27.9
Revenue % Chg.
91.4%
-6.8%
3.6%
12.2%
-56.8%
133.7%
-58.0%
229.3%
-45.7%
68.1%
Cost of Revenue
1.0
14.6
16.7
20.7
17.4
19.4
23.4
24.9
15.3
20.7
Gross Profit
19.2
4.2
2.8
1.2
-8.0
2.7
-14.1
5.6
1.3
7.2
Gross Profit Margin
95.2%
22.5%
14.2%
5.5%
-84.2%
12.3%
-151.5%
18.4%
7.7%
25.7%
Selling, General, & Admin Expenses
6.5
0.3
0.4
0.6
5.9
6.8
5.3
6.3
8.4
15.9
Other Expenses
9.1
9.0
10.8
16.5
16.5
14.3
18.7
17.0
16.6
19.5
Operating Income
3.7
-5.1
-8.5
-15.9
-30.3
-18.4
-38.3
-17.1
-23.6
-26.0
Operating Income Margin
18.1%
-26.9%
-43.5%
-72.5%
-320.4%
-83.2%
-412.1%
-55.9%
-142.4%
-93.1%
Total Other Income/Expenses Net
0.5
0.3
0.0
1.3
6.5
0.8
0.5
-1.2
-1.0
-0.9
Income Before Tax
4.1
-4.8
-8.5
-14.5
-23.8
-17.6
-37.8
-18.3
-24.6
-26.9
Income Before Tax Margin
20.5%
-25.4%
-43.4%
-66.4%
-251.7%
-79.5%
-406.7%
-59.7%
-148.2%
-96.4%
Income Tax Expense
0.5
—
—
—
—
—
-0.8
-0.1
1.6
0.9
Net Income
3.7
-4.8
-8.5
-14.5
-23.8
-17.6
-36.9
-18.1
-26.2
-27.8
Net Income Margin
18.2%
-25.4%
-43.4%
-66.4%
-251.7%
-79.5%
-397.8%
-59.3%
-157.9%
-99.8%
Weighted Avg. Shares Out
238.3
238.3
236.7
246.2
248.1
255.6
262.0
262.0
263.1
284.6
EPS
0.0
-0.0
-0.0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
EPS % Chg.
—
—
78.5%
64.5%
63.0%
28.3%
104.9%
50.9%
43.8%
1.8%
Weighted Avg. Shares Out Dil
238.3
238.3
236.7
246.2
248.1
255.6
262.0
262.0
263.1
284.6
EPS Diluted
0.0
-0.0
-0.0
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
-0.1
Interest Income
0.5
0.3
0.1
1.4
0.1
0.4
0.4
0.1
0.2
—
Interest Expense
0.7
0.0
0.3
0.2
0.0
0.0
0.3
1.3
1.6
0.9
EBIT
3.9
-4.5
-8.6
-13.3
-23.8
-17.2
-37.7
-19.4
-26.0
-27.8
EBIT Margin
19.5%
-23.7%
-44.3%
-61.0%
-251.1%
-77.9%
-406.4%
-63.6%
-156.9%
-99.8%
Depreciation & Amortization
0.4
0.9
0.9
1.0
1.0
0.9
1.1
1.3
1.2
1.4
EBITDA
4.4
-3.6
-7.7
-12.4
-22.8
-16.3
-36.6
-18.1
-24.8
-26.4
EBITDA Margin
21.7%
-19.1%
-39.6%
-56.5%
-240.6%
-73.7%
-394.0%
-59.3%
-149.5%
-94.7%